Healthcare (SH:603313) Xin Lang Cai Jing·2025-11-12 02:06Core Viewpoint - The stock of Dream Lily has shown a significant increase in price and trading activity, indicating positive market sentiment and potential growth in the home furnishings sector [1][2]. Company Performance - As of November 12, Dream Lily's stock price rose by 2.04% to 9.52 CNY per share, with a total market capitalization of 5.432 billion CNY [1]. - Year-to-date, Dream Lily's stock has increased by 42.09%, with a 0.85% rise over the last five trading days, 11.61% over the last 20 days, and 13.88% over the last 60 days [1]. - For the period from January to September 2025, Dream Lily reported a revenue of 6.756 billion CNY, reflecting a year-on-year growth of 10.29%, and a net profit attributable to shareholders of 161 million CNY, marking a substantial increase of 205.18% [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for Dream Lily was 24,100, a slight decrease of 0.17% from the previous period [2]. - The average number of circulating shares per shareholder increased by 0.17% to 23,651 shares [2]. - The company has distributed a total of 546 million CNY in dividends since its A-share listing, with 28.53 million CNY distributed over the last three years [3]. Institutional Holdings - As of September 30, 2025, notable institutional shareholders include Hua'an Ankang Flexible Allocation Mixed A, which holds 6.8838 million shares, a decrease of 2.944 million shares from the previous period [3]. - New institutional shareholders include Jiaoyin Theme Preferred Mixed A, holding 2.9665 million shares, and Ping An Research Selected Mixed A, holding 2.5813 million shares [3].